Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 13 to 40

Bulk-fill versus conventional composite for bonding orthodontic brackets

Official title: Comparison of the Brackets Bonded With Bulk Fill Composite and Conventional Composite in Patients Undergoing Fixed Orthodontic Treatment - A Split-mouth Randomized Controlled Trial

Run by Aga Khan University Hospital, Pakistan · NCT07155343 · Data updated 2026-11-12

This will test whether bonding braces with a bulk-fill composite or a conventional light-cure composite lasts longer and affects plaque or gum health in people aged 13–40 getting fixed orthodontic treatment.

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages13 Years to 40 Years
SexAll
Enrollment53 (estimated)
SponsorAga Khan University Hospital, Pakistan
Academic / other
Locations1 site (Karachi, Sindh)
StatusRecruiting
StartedJuly 21, 2025
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedSeptember 4, 2025
Trial IDNCT07155343 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 13–40 starting fixed orthodontic treatment who have good oral hygiene (plaque and gingival indices grade 1 or below) and can provide informed consent/assent.

Probably not a fit

Patients with enamel defects, existing periodontal disease, systemic illnesses (like diabetes or hypertension), pregnancy or nursing, craniofacial syndromes, or prior orthodontic treatment are excluded and may not benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients receiving fixed orthodontic treatment at Aga Khan University Hospital Karachi will have brackets bonded with bulk-fill composite on one side of the mouth and conventional light-cure composite on the other, allocated at random to right or left quadrants. The primary outcome is bracket survival time (days) and secondary outcomes are plaque accumulation and gingival health measured by plaque index and gingival index. Measurements are taken at bonding (T0) and at one, two, and three months follow-up (T1–T3). An interim analysis will be performed to monitor safety and look for early signs of effectiveness or futility.

Why it matters

Potential benefit: If successful, this could reduce how often brackets come off and help maintain better plaque and gum health during the first three months of braces.

How similar studies have gone: Previous adhesive and bonding studies have shown mixed results, and using bulk-fill composite specifically for bracket bonding is less commonly tested than conventional composites.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* • Patients aged between 13 - 40 years

  * Patients undergoing fixed orthodontic treatment
  * Patients with good oral hygiene, with grade 1 or below on plaque and gingival indices
  * All patients who will sign the informed consent/assent form

Exclusion Criteria:

* • Patients with enamel surface defects

  * Patients with any periodontal disease i.e. gingivitis or periodontitis
  * Patients with any systemic diseases i.e. diabetes and hypertension
  * Pregnant or nursing females
  * Patients with craniofacial syndromes
  * Subjects with a previous history of orthodontic or orthopedic treatment

Where it's running

  • Aga Khan University Hospital
    Karachi, Sindh, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.